Move beyond compliance
Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, Hazlehurst JM, Guo K, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hubscher SG, Newsome PN (2016) Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Clinical guidance suggests managing adverse effects through slower titration, dietary modifications, and antiemetic therapy when appropriate, rather than maintaining inadequate doses indefinitely
Emface Emface, a sister platform to Emsculpt NEO, uses similar noninvasive technology to lift and firm your face, reducing skin sagging after weight loss